The global Radiation Oncology Market was valued at USD 14.0 billion in 2025 and is projected to grow from USD 15.5 billion in 2026 to USD 33.1 billion by 2033, registering a CAGR of 11.4% from 2026 to 2033. North America accounted for the largest revenue share of 46.2% in 2025, driven by the increasing prevalence of cancer, continuous technological advancements, and growing demand for precise, targeted cancer treatment solutions.

The rising global cancer burden remains the primary growth driver for the radiation oncology industry. Aging populations, unhealthy lifestyles, tobacco consumption, obesity, environmental pollution, and genetic predisposition continue to increase cancer incidence worldwide, placing greater pressure on healthcare systems to expand oncology treatment capacity.

Radiation therapy has become one of the most important treatment modalities in modern oncology, offering highly targeted cancer treatment while preserving surrounding healthy tissues. It is widely utilized as a curative, neoadjuvant, adjuvant, and palliative treatment, making it an essential component of multidisciplinary cancer care.

According to the World Health Organization (WHO), approximately 9.7 million cancer-related deaths occurred globally in 2022, while 53.5 million people were living within five years of a cancer diagnosis. The organization also reported that 1 in 5 people develops cancer during their lifetime, with lung, breast, and colorectal cancers representing the largest disease burden. These trends continue to accelerate the adoption of advanced radiation oncology technologies worldwide.

Growing Cancer Burden Driving Market Expansion

The increasing incidence of lifestyle-related cancers is creating sustained demand for advanced radiation oncology solutions.

According to the World Health Organization, nearly 37% of global cancer cases, representing approximately 7.1 million cases, are associated with preventable risk factors including:

• Tobacco consumption
• Alcohol use
• Obesity
• Environmental pollution
• Occupational exposures

As healthcare providers emphasize early diagnosis and precision treatment, radiation oncology continues to play a central role in improving clinical outcomes while minimizing treatment-related complications.

Download a free sample copy of the Radiation Oncology Market report to understand detailed coverage and inclusions in the final report

Major healthcare markets are also experiencing rising cancer incidence. In the United States alone, the American Association for Cancer Research (AACR) estimated 2,041,910 new cancer cases and 618,120 cancer-related deaths in 2025, reinforcing the increasing demand for advanced radiation therapy systems and specialized oncology care.

Technological Innovations Transforming Radiation Oncology

Rapid technological advancements are significantly improving treatment precision, patient safety, and clinical outcomes across the radiation oncology industry.

Modern oncology centers are increasingly adopting:

• Intensity-Modulated Radiation Therapy (IMRT)
• Image-Guided Radiation Therapy (IGRT)
• Proton Therapy
• Adaptive Radiation Therapy (ART)
• Artificial Intelligence (AI)-driven treatment planning
• Automated treatment verification systems

These innovations enable clinicians to accurately target tumors while minimizing radiation exposure to healthy tissues, reducing treatment-related side effects and improving patient quality of life.

Emerging Industry Trend: Artificial Intelligence in Radiation Therapy

One of the most transformative developments in the radiation oncology market is the integration of artificial intelligence into treatment planning and workflow optimization. AI-powered software is increasingly assisting clinicians in tumor contouring, treatment planning, dose optimization, quality assurance, and adaptive therapy. This technology improves planning efficiency, reduces treatment variability, and supports more personalized cancer care, making AI one of the fastest-growing innovation areas in radiation oncology.

Key Market Trends & Insights

External Beam Radiation Therapy (EBRT) Dominates Treatment Segment

• By treatment, the External Beam Radiation Therapy (EBRT) segment accounted for the largest market share of 73.2% in 2025.
• EBRT delivers high-energy radiation beams from outside the patient's body to precisely destroy cancer cells by damaging their DNA.
• Its non-invasive nature and ability to treat tumors across multiple anatomical sites have made EBRT the most widely utilized radiation therapy modality.
• Continuous technological improvements in treatment planning and delivery continue to strengthen its clinical adoption worldwide.

Intensity-Modulated Radiotherapy (IMRT) Leads Technology Segment

• By technology, the Intensity-Modulated Radiotherapy (IMRT) segment held the largest market share of 20.4% in 2025.
• IMRT utilizes computer-controlled linear accelerators that precisely adjust radiation intensity according to the three-dimensional shape of tumors.
• This approach enables clinicians to maximize tumor targeting while significantly reducing radiation exposure to surrounding healthy organs and tissues.
• Growing demand for personalized cancer treatment is expected to further support IMRT adoption.

Looking for more specific insights? Customize this report to suite your business needs

Academic & Research Cancer Centers Account for the Largest Customer Base

• By target customer, Academic & Research Cancer Centers accounted for the largest market share of 32.2% in 2025.
• These institutions continue to lead innovation through clinical research, technology adoption, and advanced cancer treatment programs.
• Academic centers are among the earliest adopters of:
  • Image-Guided Radiation Therapy (IGRT)
  • Adaptive Radiation Therapy (ART)
  • AI-driven treatment planning
  • Precision oncology technologies
• Their strong research capabilities continue to accelerate the commercialization of next-generation radiation oncology solutions.

Regional Highlights

North America Maintains Market Leadership

• North America accounted for the largest revenue share of 46.2% in 2025.
• The region benefits from advanced healthcare infrastructure, high healthcare expenditure, favorable reimbursement systems, and widespread adoption of cutting-edge oncology technologies.
• Strong investments in cancer research and increasing availability of specialized oncology centers continue to support market growth.

United States Leads Global Market

• The U.S. held the largest market share in 2025.
• Rising cancer incidence, rapid adoption of advanced radiation therapy technologies, and the presence of leading medical device manufacturers continue to strengthen the country's market position.
• Ongoing investments in precision medicine, AI-enabled healthcare, and cancer research are expected to further accelerate market expansion.

Market Size & Forecast

• Market Size (2025): USD 14.0 Billion
• Estimated Market Size (2026): USD 15.5 Billion
• Projected Market Size (2033): USD 33.1 Billion
• CAGR (2026–2033): 11.4%
• Largest Regional Market: North America
• Leading Country: United States

Competitive Landscape

The global radiation oncology market is highly competitive, with leading companies focusing on technological innovation, strategic collaborations, product development, and geographic expansion to strengthen their market presence.

Key competitive strategies include:

• Development of next-generation radiation therapy systems
• AI-integrated treatment planning software
• Expansion of proton therapy capabilities
• Government and hospital partnerships
• Strategic mergers and acquisitions
• Research and development investments
• Clinical validation of advanced treatment technologies

Established industry leaders benefit from comprehensive product portfolios, extensive global distribution networks, and long-standing relationships with hospitals, cancer centers, and research institutions.

Emerging companies are differentiating themselves by developing innovative radiation delivery systems that offer improved treatment accuracy, faster workflows, enhanced usability, and greater patient comfort. However, these companies may face challenges related to regulatory approvals, capital investment requirements, and intense competition from established market participants.

Explore Grand View Horizon to see global and regional level statistics related to the Radiation Oncology Market  

Key Radiation Oncology Companies

The following companies are among the leading participants in the global radiation oncology market:

• Varian Medical Systems, Inc. (Siemens Healthineers)
• Elekta AB
• Accuray Incorporated
• IBA (Ion Beam Applications)
• BD (Becton, Dickinson and Company)
• Curium
• Panacea Medical Technologies
• Mevion Medical Systems
• Canon Medical Systems Corporation
• Sumitomo Heavy Industries, Ltd.

Conclusion

The global radiation oncology market is poised for strong growth as cancer incidence continues to rise worldwide and healthcare providers increasingly adopt precision-based treatment technologies. Radiation therapy remains a cornerstone of modern oncology care, offering effective treatment across curative, adjuvant, neoadjuvant, and palliative settings.

Continuous advancements in IMRT, IGRT, proton therapy, adaptive radiation therapy, and AI-powered treatment planning are transforming cancer care by improving treatment precision, reducing toxicity, and enhancing patient outcomes. With North America maintaining market leadership and emerging economies expanding investments in oncology infrastructure, the radiation oncology market is expected to witness sustained innovation and long-term growth throughout the forecast period.

Looking for a report customized to your requirements? Explore our Custom Research Offering

Grand View Research offers

• Focused market intelligence reports on specific geographies or high-growth segments
• Extended forecast timelines for long-term planning
• Competitor Benchmarking and Supply Chain Analysis
• Inclusion of regulatory and policy assessments
• Inclusion of custom data models, KPIs, or applications unique to your business
• Specific high-impact Data Decks and Tables to support effective decision making

And much more…